Pharmacotherapy in dentistry: analysis of the use of drugs in dentistry in 2021

Abstract

Background. Every year the pharmaceutical market of Ukraine is replenished with new modern medicines, and the rationality of their use remains an urgent problem for doctors around the world. The introduction of a large number of drugs on the pharmaceutical market and the use in the practice of dentists is relevant not only in providing medical professionals with timely and complete information on the clinical efficacy of the drug, but also the features of use, safety, and possible side effects. The purpose of the study was a monitoring, comparative analysis of the results of prescriptions of pharmaceuticals and oral care products by dentists of Ukraine in 2021. Materials and methods. A survey of dentists and analysis of the results of the study was conducted under the auspices of the public organization “Association of Dentists of Ukraine”, a group of companies “MedExpert”, and the Ukrainian rating agency. The study enrolled 4026 respondents — dentists from all regions of Ukraine. There were 70.25 % of women and 29.75 % of men among the respondents. According to the demographic distribution, the largest number of respondents was from the city of Kyiv (1003 people), Lviv (577 people), Kyiv (482 people) regions, the smallest — from Kirovohrad (16 people) and Luhansk (14 people) regions. The study was phased, by filling out a questionnaire prepared by the NGO “Association of Dentists of Ukraine” during scientific and practical events, conferences of professional schools for dentists, online in the first half of 2021. The subject of the study was to determine the purpose of the main pharmaceutical drugs and oral care products. Respondents were dentists of various specialties, mostly of therapeutic and surgical profile. Results. Studies have shown that dentists widely use pharmaceuticals in their daily practice; a significant number of dentists regularly prescribe antibacterial drugs, namely combined antibiotics — ciprofloxacin with tinidazole (48.36 %), penicillin (40.86 %), metronidazole (34.53 %). For pain reduction, a large proportion of dentists uses nonsteroidal anti-inflammatory drugs from the group of nimesulide (85.89 %). Almost all dentists in their daily practice use tools for local treatment of infectious and inflammatory processes: chlorhexidine (82.51 %), metrogil-dent (67.51 %), local anti-inflammatory drugs (holisal) (47.54 %). The purpose of oral care products — kinds of toothpaste, rinses, toothbrushes was analyzed. Conclusions. The results of the analysis of the prescriptions of pharmaceuticals and oral care products testify to their widespread introduction in daily practice by dentists, informing dentists about modern pharmaceuticals and oral care products, data on their indications and contraindications, the likely interaction of pharmaceuticals that will affect the achievement of highly effective treatment results.